tag:blogger.com,1999:blog-5495065931245897039.post7171524256247052516..comments2024-02-27T15:47:47.923-05:00Comments on Principled Perspectives: On Mylan’s EpiPen Pricing Controversyprincipled perspectiveshttp://www.blogger.com/profile/06502754865268315342noreply@blogger.comBlogger3125tag:blogger.com,1999:blog-5495065931245897039.post-85564401771665633002016-10-05T13:25:38.208-04:002016-10-05T13:25:38.208-04:00Good points, Mike. I like your description of the ...Good points, Mike. I like your description of the FDA policies as a "blockade." It fits. Yes, I kinow about the Vanderbilt saga and AR's essay. Thanks.principled perspectiveshttps://www.blogger.com/profile/06502754865268315342noreply@blogger.comtag:blogger.com,1999:blog-5495065931245897039.post-59302763179552520032016-10-04T15:20:37.154-04:002016-10-04T15:20:37.154-04:00I just remembered, you don't have to go to Jef...I just remembered, you don't have to go to Jeff Britting to get filled in on "Notes On the History of American Free Enterprize"('z', this time). That article is in Ayn Rand's, Capitalism: the Unknown Ideal. That's where I last read it, long ago. I forgot. Previously, it appeared as a small pamphlet, and in one of her first two periodicals, The Objectivist Newsletter, and The Objectivist,. I don't remember which one.Mike Kevitthttps://www.blogger.com/profile/09725778137382703642noreply@blogger.comtag:blogger.com,1999:blog-5495065931245897039.post-6450671521887952412016-10-03T22:02:21.987-04:002016-10-03T22:02:21.987-04:00The opportunity taken advantage of by Mylan was pr...The opportunity taken advantage of by Mylan was provided by the FDA, based on legislation going back to about 1905, maybe due to underfunding by Congress, underfunding in this perverted case being bad, not good. Governments don't provide markets. 'They' distort them. In this case, that's why Mylan had no competition. Entry of competition was effectively blocked by initiatory force from what's supposed to be government. The company that invented the EpiPen got around the blockade somehow, probably after years or decades of FDA blockage that shielded older inventions. So now, it's EpiPen's (Mylan's) turn at the trough. I don't blame Mylan. That's the regime (I won't say game; it's for keeps) wielded by crooks, meaning by initiatory force. Mylan has to work the regime for its existence.<br /><br />New entities are trying to compete? They'll have to spend years running the blockade. Without FDA interference, Mylan might've never bought the EpiPen patent. The inventor would've kept it and the price would've stayed low because of actual competition from other inventions, or the inventor would've invented something even better. But, as it is, if new entities successfully run the blockade, they'll still have to have their turn at the trough, just like Mylan. That's the regime, set up by what's supposed to be law and government.<br /><br />It was the same 150 years ago. Cornelius Vanderbilt had to play the regime several times to do what he had the individual right to do, and he won. (That wasn't the first time he upended someone trying to pull a fast one.) He built the N.Y. Central R.R. Read, "Notes On the History of American Free Enterprise", by Ayn Rand. Jeff Britting, of the Ayn Rand Archives, at the ARI, can fill you in. I assume he knows he can.Mike Kevitthttps://www.blogger.com/profile/09725778137382703642noreply@blogger.com